The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAdvanced Medical Solutions Group Regulatory News (AMS)

Share Price Information for Advanced Medical Solutions Group (AMS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 195.40
Bid: 194.80
Ask: 195.60
Change: 2.40 (1.24%)
Spread: 0.80 (0.411%)
Open: 192.40
High: 195.60
Low: 192.00
Prev. Close: 193.00
AMS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

20 Sep 2017 17:04

RNS Number : 3478R
Advanced Medical Solutions Grp PLC
20 September 2017
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

ADVANCED MEDICAL SOLUTIONS GROUP PLC

 

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

CANACCORD GENUITY GROUP INC

City and country of registered office (if applicable)

VANCOUVER, CANADA

4. Full name of shareholder(s) (if different from 3.)v

Name

DISCRETIONARY CLIENTS

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

18 SEPTEMBER 2017

6. Date on which issuer notified (DD/MM/YYYY):

20 SEPTEMBER 2017

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

7.0100%

0.00

7.0100%

212,118,648

Position of previous notification (if

applicable)

N/A

N/A

N/A

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB0004536594

N/A

14,869,550

N/A

7.0100%

SUBTOTAL 8. A

14,869,550

7.0100%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

X

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Canaccord Genuity Group Inc.[1]

7.0100%

7.0100%

Canaccord Genuity Wealth Group Holdings Limited

7.0100%

7.0100%

Canaccord Genuity Wealth Group Holdings (Jersey) Limited

7.0100%

7.0100%

Hargreave Hale Limited

6.0142%

6.0142%

Canaccord Genuity Wealth Group Limited

0.9958%

0.9958%

Canaccord Genuity Wealth Limited

0.9958%

0.9958%

[1] Each company set out in this table is ultimately owned by Canaccord Genuity Group Inc.

 

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

This disclosable event is as a result of the acquisition of Hargreave Hale Limited by Canaccord Genuity Group Inc., through its wholly-owned subsidiary Canaccord Genuity Wealth Group Holdings (Jersey) Limited.

 

 

 

Place of completion

London

Date of completion

20 September 2017

 


 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLURRNRBUAKUAR
Date   Source Headline
13th May 201311:53 amRNSHolding(s) in Company
22nd Apr 201312:33 pmRNSAnnual Financial Report
6th Mar 20137:00 amRNSFinal Results
26th Feb 20131:47 pmRNSNotice of Results
20th Feb 20132:49 pmRNSHolding(s) in Company
31st Jan 201311:41 amRNSTotal Voting Rights
18th Jan 20134:55 pmRNSHolding(s) in Company
16th Jan 20131:31 pmRNSHolding(s) in Company
31st Dec 20128:35 amRNSTotal Voting Rights
20th Dec 20125:43 pmRNSHolding(s) in Company
17th Dec 20125:18 pmRNSHolding(s) in Company
17th Dec 20122:37 pmRNSDirector/PDMR Shareholding
13th Dec 20127:00 amRNSTrading Update
30th Nov 20123:54 pmRNSTotal Voting Rights
31st Oct 20124:22 pmRNSTotal Voting Rights
28th Sep 20124:09 pmRNSTotal Voting Rights
7th Sep 20121:33 pmRNSDirector/PDMR Shareholding
5th Sep 20127:00 amRNSHalf Yearly Report
31st Aug 20124:00 pmRNSTotal Voting Rights
2nd Aug 20129:00 amRNSNotice of Results
31st Jul 20127:00 amRNSTotal Voting Rights
5th Jul 20122:45 pmRNSDirector/PDMR Shareholding
4th Jul 20121:56 pmRNSHolding(s) in Company
29th Jun 20125:39 pmRNSTotal Voting Rights
12th Jun 201212:15 pmRNSResult of AGM
12th Jun 20127:00 amRNSAGM Statement
31st May 20123:27 pmRNSTotal Voting Rights
11th May 20125:07 pmRNSTransaction in Own Shares
10th May 20121:50 pmRNSAnnual Financial Report
30th Apr 20129:35 amRNSTotal Voting Rights
16th Apr 20122:03 pmRNSHolding(s) in Company
7th Mar 20127:00 amRNSFinal Results
1st Mar 20127:00 amRNSNotice of Results
20th Jan 20124:41 pmRNSHolding(s) in Company
3rd Jan 201210:34 amRNSHolding(s) in Company
28th Dec 20117:42 amRNSHolding(s) in Company
22nd Dec 201112:11 pmRNSHolding(s) in Company
21st Dec 20113:16 pmRNSHolding(s) in Company
20th Dec 20118:20 amRNSCompletion of Acquisition
19th Dec 201111:58 amRNSResult of General Meeting
9th Dec 201111:33 amRNSHolding(s) in Company
9th Dec 201110:30 amRNSHolding(s) in Company
2nd Dec 20117:00 amRNSAcquisition of RESORBA
10th Nov 20119:46 amRNSInvestor Site Visit
19th Oct 20114:59 pmRNSHolding(s) in Company
17th Oct 201110:42 amRNSAdditional Listing
7th Sep 20117:00 amRNSHalf Yearly Report
1st Sep 20117:00 amRNSRe Agreement
1st Sep 20117:00 amRNSAgreement with Surgical Innovations Group
4th Aug 20117:00 amRNSOption and Licensing agreement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.